Medicine usage data available as GIRFT metrics for dermatology are added to the Model Health System

NHS dermatology teams can now access GIRFT data for the specialty on the Model Health System (MHS), supporting them to better understand their service and identify where improvements are needed.

The new GIRFT compartment for dermatology contains around 90 metrics, including data on the use of medicines for psoriasis, eczema and acne – the first time medicines metrics have been added to a GIRFT specialty.

Data can be viewed at provider or system level, with comparisons possible between trusts and ICBs.

As well as contextual metrics indicating volumes and percentages, the new dermatology metrics also include an overview of outpatient services, and data for biopsies, excisions, Mohs surgery for skin cancer, patch testing for eczema, and phototherapy for psoriasis.

To access data for your unit, log in to and navigate to ‘acute hospital services’ > dermatology > GIRFT metrics.

"We have worked hard to select the metrics we think will be of most use to the service, and I am delighted that we are now able to share this data on the Model Health System, allowing our colleagues to identify where there are opportunities for improvement and to gauge their progress. I hope everyone will log in to see what’s on offer for their trust or system, to support the national drive to improve quality of care for patients.”

GIRFT’s national report for dermatology – authored by Professor Levell – was published in 2021 following deep dive visits to 80 units in England, meeting with clinicians, managers, nurses and members of the wider multidisciplinary team, including GPs.  

The report showed that one in four people in England and Wales (13.2m) see their GP about a skin, nail or hair condition every year, with more than 3.5m outpatient and day surgery attendances in dermatology. Skin cancer now accounts for half of all cancers in England and Wales with some types increasing by 8% annually; NHS dermatology units carry out around 200,000 procedures to surgically remove malignant moles, lesions and tumours every year.

More updates